Display options
Share it on

Front Mol Biosci. 2021 Jun 16;8:685135. doi: 10.3389/fmolb.2021.685135. eCollection 2021.

SmgGDS: An Emerging Master Regulator of Prenylation and Trafficking by Small GTPases in the Ras and Rho Families.

Frontiers in molecular biosciences

Anthony C Brandt, Olivia J Koehn, Carol L Williams

Affiliations

  1. Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI, United States.

PMID: 34222337 PMCID: PMC8242357 DOI: 10.3389/fmolb.2021.685135

Abstract

Newly synthesized small GTPases in the Ras and Rho families are prenylated by cytosolic prenyltransferases and then escorted by chaperones to membranes, the nucleus, and other sites where the GTPases participate in a variety of signaling cascades. Understanding how prenylation and trafficking are regulated will help define new therapeutic strategies for cancer and other disorders involving abnormal signaling by these small GTPases. A growing body of evidence indicates that splice variants of SmgGDS (gene name RAP1GDS1) are major regulators of the prenylation, post-prenylation processing, and trafficking of Ras and Rho family members. SmgGDS-607 binds pre-prenylated small GTPases, while SmgGDS-558 binds prenylated small GTPases. This review discusses the history of SmgGDS research and explains our current understanding of how SmgGDS splice variants regulate the prenylation and trafficking of small GTPases. We discuss recent evidence that mutant forms of RabL3 and Rab22a control the release of small GTPases from SmgGDS, and review the inhibitory actions of DiRas1, which competitively blocks the binding of other small GTPases to SmgGDS. We conclude with a discussion of current strategies for therapeutic targeting of SmgGDS in cancer involving splice-switching oligonucleotides and peptide inhibitors.

Copyright © 2021 Brandt, Koehn and Williams.

Keywords: GDF; GEF; Rap1GDS1; SmgGDS; lipidation; prenylation; splicing; trafficking

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  1. J Biol Chem. 2011 Apr 8;286(14):12141-8 - PubMed
  2. Nat Rev Mol Cell Biol. 2011 Jul 22;12(8):493-504 - PubMed
  3. Bioessays. 2005 Jun;27(6):602-13 - PubMed
  4. Nat Chem Biol. 2011 Oct 16;7(12):942-9 - PubMed
  5. J Clin Invest. 2011 Feb;121(2):628-39 - PubMed
  6. Dev Cell. 2015 Feb 9;32(3):318-34 - PubMed
  7. J Biol Chem. 2008 Jan 11;283(2):963-76 - PubMed
  8. Biochem J. 2020 Aug 14;477(15):2893-2919 - PubMed
  9. Ophthalmic Genet. 2004 Jun;25(2):101-10 - PubMed
  10. Nat Rev Mol Cell Biol. 2016 Feb;17(2):110-22 - PubMed
  11. J Lipid Res. 2006 Apr;47(4):681-99 - PubMed
  12. Circulation. 2018 Nov 20;138(21):2413-2433 - PubMed
  13. Cell Mol Life Sci. 2017 Feb;74(3):525-541 - PubMed
  14. Nature. 2003 Oct 23;425(6960):856-9 - PubMed
  15. Angew Chem Int Ed Engl. 2020 Apr 16;59(16):6342-6366 - PubMed
  16. Ann Clin Transl Neurol. 2020 Jun;7(6):956-964 - PubMed
  17. Mol Cell Biol. 1991 May;11(5):2873-80 - PubMed
  18. J Lipid Res. 2006 Mar;47(3):467-75 - PubMed
  19. J Biol Chem. 2006 Nov 24;281(47):35954-64 - PubMed
  20. J Biol Chem. 2001 Jul 27;276(30):28219-25 - PubMed
  21. EMBO J. 1997 Feb 3;16(3):465-72 - PubMed
  22. Nat Rev Cancer. 2010 Dec;10(12):842-57 - PubMed
  23. J Biol Chem. 1990 Sep 25;265(27):16626-34 - PubMed
  24. J Biol Chem. 2014 Mar 7;289(10):6862-6876 - PubMed
  25. Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):E6766-E6775 - PubMed
  26. Bioorg Med Chem. 2018 May 1;26(8):1426-1434 - PubMed
  27. J Bone Miner Res. 2006 May;21(5):684-94 - PubMed
  28. Biochem Biophys Res Commun. 1991 Feb 14;174(3):1095-102 - PubMed
  29. Cancer Biol Ther. 2015;16(9):1364-74 - PubMed
  30. J Mol Biol. 2016 Dec 4;428(24 Pt B):4929-4945 - PubMed
  31. Proc Natl Acad Sci U S A. 2018 Sep 18;115(38):9563-9568 - PubMed
  32. Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6442-6 - PubMed
  33. Cell. 2021 May 13;184(10):2649-2664.e18 - PubMed
  34. Nat Rev Clin Oncol. 2020 Aug;17(8):457-474 - PubMed
  35. Cell Cycle. 2014;13(6):941-52 - PubMed
  36. J Mol Biol. 2001 May 25;309(1):1-18 - PubMed
  37. J Biol Chem. 1994 May 27;269(21):15085-91 - PubMed
  38. Mol Cell. 2003 Nov;12(5):1064-6 - PubMed
  39. J Cell Physiol. 2019 May;234(5):5564-5577 - PubMed
  40. Crit Rev Biochem Mol Biol. 2015;50(3):194-202 - PubMed
  41. Nucleic Acids Res. 2016 Aug 19;44(14):6549-63 - PubMed
  42. Trends Mol Med. 2002 Jan;8(1):23-30 - PubMed
  43. J Biol Chem. 2020 Jan 31;295(5):1300-1314 - PubMed
  44. Nat Rev Drug Discov. 2007 Jul;6(7):541-55 - PubMed
  45. J Biol Chem. 1991 Feb 15;266(5):2962-9 - PubMed
  46. J Biol Chem. 1991 Nov 5;266(31):20672-7 - PubMed
  47. J Biol Chem. 2017 Aug 11;292(32):13441-13448 - PubMed
  48. J Biol Chem. 2010 Nov 12;285(46):35255-66 - PubMed
  49. Proc Natl Acad Sci U S A. 2020 Feb 18;117(7):3627-3636 - PubMed
  50. PLoS One. 2011 Feb 24;6(2):e17380 - PubMed
  51. Biochem Biophys Res Commun. 1992 Jan 31;182(2):921-30 - PubMed
  52. Mol Cancer Res. 2014 Jan;12(1):130-42 - PubMed
  53. Am J Physiol Heart Circ Physiol. 2014 Aug 1;307(3):H379-90 - PubMed
  54. Nat Cell Biol. 2020 Jul;22(7):868-881 - PubMed
  55. J Cell Biol. 2016 Aug 15;214(4):445-58 - PubMed
  56. Physiol Rev. 2011 Jan;91(1):119-49 - PubMed
  57. J Biol Chem. 2003 Apr 4;278(14):12495-506 - PubMed
  58. Front Mol Biosci. 2018 Sep 07;5:80 - PubMed
  59. Stem Cell Reports. 2015 May 12;4(5):926-38 - PubMed
  60. J Cell Biol. 2008 May 5;181(3):485-96 - PubMed
  61. J Biol Chem. 1992 Dec 25;267(36):25709-13 - PubMed
  62. Cell Cycle. 2013;12(18):2933-4 - PubMed
  63. J Lipid Res. 2006 May;47(5):883-91 - PubMed
  64. Biochemistry. 1997 Jan 21;36(3):626-32 - PubMed
  65. Stem Cell Res. 2017 Dec;25:157-165 - PubMed
  66. Oncogene. 2017 Dec 14;36(50):6873-6883 - PubMed
  67. Biochem Biophys Res Commun. 1993 Feb 15;190(3):832-41 - PubMed
  68. Small GTPases. 2016 Oct;7(4):207-221 - PubMed
  69. Biochem Biophys Res Commun. 1994 Jan 28;198(2):811-7 - PubMed
  70. Clin Cancer Res. 2015 Apr 15;21(8):1819-27 - PubMed
  71. Cell Mol Life Sci. 2005 Aug;62(15):1657-70 - PubMed
  72. Circulation. 2013 Feb 19;127(7):782-90 - PubMed
  73. Mol Cell Biol. 1992 Aug;12(8):3407-14 - PubMed
  74. J Pathol. 2009 Feb;217(3):389-97 - PubMed
  75. Cancer Cell. 2017 Feb 13;31(2):256-269 - PubMed
  76. Oncogene. 2003 Sep 18;22(40):6243-56 - PubMed
  77. Methods Enzymol. 2000;325:71-82 - PubMed
  78. Small GTPases. 2016 Jul 2;7(3):123-38 - PubMed
  79. Proc Natl Acad Sci U S A. 2007 Jul 24;104(30):12294-9 - PubMed
  80. J Biol Chem. 1993 Dec 5;268(34):25542-6 - PubMed
  81. Biochem J. 1994 Nov 1;303 ( Pt 3):761-7 - PubMed
  82. Mol Biol Cell. 2012 Oct;23(20):4097-108 - PubMed
  83. Small GTPases. 2016 Oct;7(4):222-230 - PubMed
  84. Genes Cancer. 2013 Nov;4(11-12):460-75 - PubMed
  85. Biophys J. 2010 Nov 17;99(10):3327-35 - PubMed
  86. Sci Signal. 2013 May 28;6(277):ra39 - PubMed
  87. Biochemistry. 2018 Jul 24;57(29):4289-4298 - PubMed
  88. J Thorac Dis. 2018 Nov;10(Suppl 33):S4133-S4136 - PubMed
  89. J Biol Chem. 2016 Mar 18;291(12):6534-45 - PubMed
  90. Small GTPases. 2013 Jul-Sep;4(3):159-63 - PubMed
  91. Small GTPases. 2017 Oct 2;8(4):208-211 - PubMed
  92. J Biol Chem. 2004 Oct 15;279(42):44197-210 - PubMed
  93. J Biol Chem. 1992 Jul 25;267(21):14611-5 - PubMed
  94. Nat Chem Biol. 2011 Nov 15;7(12):863-4 - PubMed
  95. J Biol Chem. 1992 Jan 15;267(2):926-30 - PubMed
  96. Cancer Treat Rev. 2020 Sep;89:102070 - PubMed
  97. Cell Signal. 2015 Mar;27(3):630-7 - PubMed
  98. J Biol Chem. 1992 May 25;267(15):10215-8 - PubMed
  99. J Biol Chem. 2008 Sep 12;283(37):25150-25163 - PubMed
  100. Nat Commun. 2019 Sep 4;10(1):3975 - PubMed
  101. Clin Cancer Res. 2010 Jan 1;16(1):65-76 - PubMed
  102. J Biol Chem. 2019 Aug 2;294(31):11793-11804 - PubMed
  103. Dev Cell. 2018 Jan 22;44(2):248-260.e4 - PubMed
  104. Biochemistry. 2000 Sep 19;39(37):11348-59 - PubMed
  105. Nat Med. 2018 Jul;24(7):968-977 - PubMed
  106. Nat Genet. 2019 Sep;51(9):1308-1314 - PubMed

Publication Types

Grant support